Board Oversight Committee

Dr. Angelique Chan holds joint appointments as Associate Professor in the Signature Program in Health Services & Systems Research, Duke-NUS Medical School and the Department of Sociology, NUS. She is the Inaugural Executive Director of the Centre for Ageing Research & Education (CARE, Duke-NUS). Dr Chan obtained her undergraduate degree, BA (Sociology) from Reed College, her PhD (Sociology) from the University of California at Los Angeles as a Rockefeller Foundation PhD fellowship awardee, and a US National Institute of Aging Post-Doctoral degree at the University of Michigan.

Dr. Chan‘s current research examines disability transitions, mortality, and the effects of social support on health, caregiver burden, and use of long-term care services. She has published widely on aging issues in leading international journals including the Journal of American Geriatrics Society, Journal of Aging and Health, and Journal of Gerontology Series B: Social Sciences and book chapters. She is co-author of a book titled Ageing in Singapore: Service Needs & the State (Routledge 2006) and Co-editor of Ultra-low Fertility in Pacific Asia: Trends, Causes and Policy Issues (Routledge 2009).

Her international work includes working with collaborators from Japan and USA on caregiving, work and retirement, and disability transitions. She has consulted for various local Singapore governments entities and international bodies such as the UNESCAP, The World Bank and the Asian Development Bank.

1. Chief Executive Officer / Medical Director, Singapore National Eye Centre
2. Chair, Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School
3. Kwan Im Thong Hood Cho Temple Professor of Ophthalmology and Associate Dean, Duke-NUS Medical School
4. Group Director, Research (Scientific), SingHealth
5. Chairman of Board, Singapore Eye Research Institute
6. Senior Consultant, Glaucoma Department, Singapore National Eye Centre

Professor Aung is a clinician scientist whose research has secured more than S$20 million in competitive research grant funding, and he is currently the Lead PI of the Large Collaborative Grant (LCG), “Tackling and Reducing Glaucoma Blindness with Emerging Technologies (TARGET), a $25 million multi-disciplinary and multicenter program grant awarded by the National Medical Research Council, Singapore in 2022. Prof Aung was awarded the Nakajima Award (2007) and De Campo Award (2013) by the Asia Pacific Academy of Ophthalmology, the Alcon Research Institute Award (2013), the Singapore Translational Research (STaR) Investigator Award (2014, and 2020), the Robert Ritch Award for Excellence and Innovation in Ophthalmology by the Glaucoma Foundation (2017), as well as numerous other awards/medals.

Professor Aung currently has more than 700 publications including 15 major papers in Nature Genetics (6 as First or last author) as well as multiple papers in JAMA and Lancet. Prof Aung has delivered more than 200 Invited Lectures at many international meetings around the world including several named lectures. He is a member of the Editorial Boards of Ophthalmology, Eye, Progress in Retinal and Eye Research and Graefe’s Archive for Clinical Experimental Ophthalmology, as well as 5 other journals.

Professor Aung was President of the World Glaucoma Association from 2016-2017 and he also serves as Board Member of the World Glaucoma Association and Asia Pacific Glaucoma Society. He was President of the College of Ophthalmologists of Singapore from 2012-2014 and President of the Singapore Society of Ophthalmology from 2009-2011.

Professor Aung is actively involved in medical education of undergraduates and post graduates. He supervises and mentors Research Fellows, Trainees and Students, especially in the areas of glaucoma and translational research.

As Deputy Secretary (Technology) at MOH, Dr Cheong deploys technology against COVID-19, and develops the health research and innovation ecosystem to achieve Healthier SG – i.e. population health, precision health and preventive health. He sits on the Board of Integrated Health Information Systems (IHiS).

Prior to MOH, he was Deputy CEO of National Research Foundation (NRF), where he oversaw the implementation of the S$19 billion Research Innovation and Enterprise (RIE) 2020 plan and led an inter-agency effort to develop the S$25 billion RIE 2025 plan.

Dr Cheong was also Divisional Director (Planning) in MOE. Beyond educational policies, he shaped educational research at National Institute of Education, international benchmarking and partnership efforts. As Deputy Director (Manufacturing & Services) at MTI, he oversaw EDB, and the Secretariat for Economic Strategies Committee chaired by Senior Minister Tharman Shanmugaratnam. As Head Fiscal Strategy at Ministry of Finance, he shaped Singapore’s long-term fiscal sustainability.

He served on the Boards of URA; ISEAS-Yusof Ishak Institute; NMRC; EDDC; DxD Hub; National Additive Manufacturing Programme; Singapore Food Story R&D Programme and NRF Holdings. He continues to serve on the Boards of Advanced Cell Therapy and Research Institute of Singapore (ACTRIS), Centre for Research & Development in Learning (CRADLE), National Clinical Trial Steering Committee (NCTSC) and Precision Health Research Singapore (PRECISE).

As a Rhodes Scholar and PSC Scholar, he obtained his DPhil/Mphil in Economics from Oxford, and his S.B. in Chemical Engineering and S.B. in Economics from Massachusetts Institute of Technology.

A/Prof Dan Yock Young is Deputy Director-General of Health (Health Services Group), Ministry of Health; Associate Professor, Dept of Medicine, National University Singapore; Senior Consultant, Division of Gastroenterology and Hepatology, National University Hospital; and is an Associate with the Cancer Science Institute, National University of Singapore and Genome Institute Singapore, Agency for Science, Technology & Research.

As DDGH, A/Prof Dan oversees organisational healthcare services and provision in public hospitals, primary care as well as integration with community partners. This includes oversight of mental health and complementary health services. He co-chairs efforts in healthcare transformation specifically looking at reorganisation of primary care as well as establishment of longitudinal care models that will be future-ready for Singapore’s needs.

In his academic portfolio, his research interest is in liver stem cells and their applications in liver regeneration and cancer. He is clinical lead of the multi-centre EMULSION programme which aims to unravel the disease of non-alcohol fatty liver disease and its contribution to the metabolic burden in the population. He also co-chairs GOASIA group, an Asia-Pacific effort to address gastrointestinal diseases in association with obesity in Asia.

Dr. Daphne Khoo is the Deputy Director-General of Health (Healthcare Performance Group) and, concurrently, Executive Director of the Agency of Care Effectiveness (ACE), Ministry of Health, Singapore (MOH). The mission of ACE is to drive appropriate care in Singapore through the application of Health Technology Assessment.

Dr. Khoo is an endocrinologist by training and was previously Head of Endocrinology at Singapore General Hospital (SGH). From 2004 to 2011, she was the Director of Clinical Governance and Quality Management of the SingHealth cluster and also served as their Director of Enterprise Risk. She is a past-President of the Association of Women Doctors, Singapore as well as the Association of South East Asian Nations Federation of Endocrine Societies.

From 2011 to 2014, she worked in the private sector as a Chief Medical Officer managing healthcare facilities in 11 countries.

Dr Fidah Alsagoff is currently Joint Head of Enterprise Development Group and Head of Life Sciences at Temasek International Pte Ltd, where he has been since 2008.

He was previously a Partner at Innosight Ventures Private Limited, and prior to that, was Chief Executive Officer of MOH Holdings. His career also includes nearly a decade in social entrepreneurship where he started up several programs and enterprises catering to hitherto unmet healthcare needs of patients, with the latest enterprise being the establishment of the Singapore Cord Blood Bank.

Fidah graduated from the National University of Singapore with a Bachelors of Medicine and Surgery, and later with a Masters of Medicine in Public Health. He attended INSEAD on a Lee Kuan Yew Scholarship for post-graduate studies, and subsequently graduated with an Executive MBA (with distinction). As valedictorian of his EMBA class, he was awarded the Claude Janssen Prize.

Fidah currently serves on the Board of Trustees of the Singapore University of Technology and Design and on the Governing Board of the Duke-NUS Medical School.

Professor Sung received his medical degree (MBBS) from The University of Hong Kong, and conferred PhD in biomedical sciences by the University of Calgary and MD by The Chinese University of Hong Kong (CUHK). He holds fellowships from the Royal Colleges of Physicians of Edinburgh, Glasgow, London, and Australia, the American College of Gastroenterology, the American Gastroenterological Association, the Hong Kong College of Physicians, the Hong Kong Academy of Medicine and Academy of Sciences of Hong Kong (ASHK). He is an Academician of the Chinese Academy of Engineering of the People’s Republic of China and Academician of the International Eurasian Academy of Sciences.

He served as the Vice-Chancellor and President of the Chinese University of Hong Kong from 2010-2017 and the Chair of Worldwide Universities Network (WUN) in 2016-17. He is currently Emeritus Professor in Medicine of CUHK.

Professor Sung has published over 1000 full scientific articles in leading medical and scientific journals. He was listed as “Highly Cited Researchers”, released by the Clarivate Analytics, for the years 2018, 2019 and 2020. He has edited and authored around 30 books, as well as many chapters in major textbooks including the Oxford Textbook of Medicine (5th Ed.), Fordtran and Slanginger Textbook of Gastroenterology (7th Ed) and Yamada’s Textbook of Gastroenterology (4th Ed).

From 1 April 2021, Prof Sung assumed the role of Distinguished University Professor, Senior Vice President (Health & Life Sciences) and Dean, Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore.

Professor Ng Huck Hui is the Assistant Chief Executive of the Biomedical Research Council, under the Agency for Science, Technology and Research.

Prof Ng is renowned in the field of gene regulation and genomics. His laboratory is developing diagnostic and therapeutics modalities for brain and liver diseases. Prof Ng had held several administrative positions. He was the Executive Director of the Genome Institute of Singapore and the Executive Director of the A*STAR Graduate Academy.

Prior to joining A*STAR, Prof Ng was a postdoctoral fellow with Harvard Medical School under the prestigious Damon Runyon-Walter Winchell Postdoctoral Fellowship. Prof Ng is renowned in the field of stem cells, having spent more than a decade in research to understand and uncover the intricacies of gene regulation and how they relate to cell biology. He was also the President for the Stem Cell Society Singapore, which is a major platform for educating the public on stem cell research. In 2016, Prof Ng was elected to be an Associate Member of the European Molecular Biology Organization, making him the only associate member to be based in Singapore. Most recently, Prof Ng was also elected as Fellow of the Singapore Academy of Science (SNAS).

In recognition of his scientific contributions, Prof Ng has received numerous local and international honours and awards, including the Young Scientist Award in 2004, Singapore Youth Award in 2005, National Science Award in 2007, Junior Chamber International (JCI) The Outstanding Young Persons Singapore Awards in 2009, Singapore Youth Award (Commendation Medal) in 2010, President’s Science Award (Team Award) in 2011, President’s Science Award (Team Award) in 2018 and The Public Administration Medal (Silver), National Day Awards 2019.

Outside of A*STAR, Prof Ng is very active in the local universities and organizations, and holds adjunct positions at the National University of Singapore (NUS) Yong Loo Lin School of Medicine, NUS Faculty of Science, Nanyang Technological University (NTU) School of Biological Sciences and LKC Medicine and the Singapore Eye Research Institute (SERI). He also sits on the Board of Consortium for Clinical Research and Innovation Singapore (CRIS) Pte Ltd, National Medical Research Council (NMRC), Science Centre Singapore and NUS High School.

A/Prof (Dr) Raymond Chua graduated from the Faculty of Medicine in National University of Singapore in 1997. He holds a Masters in Public Health (London School of Hygiene and Tropical Medicine, 2002) and is a Registered Public Health specialist and Fellow with the Academy of Medicine, Singapore.

His career spans both public service and private sector industry (as Managing Director of Eisai Clinical Research Singapore, and International Medical Director with Shire Pharmaceuticals). In 2012, A/Prof Chua was designated as Group Director of the Health Products Regulation Group in the Health Sciences Authority. Since 2017, he has joined the Ministry of Health as Deputy Director-General of Health, Health Regulation Group to oversee and reform the regulations of healthcare services and premises in Singapore, so as to safeguard public health. He also holds other adjunct academic appointments, including an Adjunct Associate Professor in the Saw Swee Hock School of Public Health in National University of Singapore and Centre of Regulatory Excellence in Duke-NUS.

Roger Foo is the inaugural Zayed bin Sultan Al Nahyan Professor of Medicine at the NUS Yong Loo Lin School of Medicine, Director of the NUHS Cardiovascular Disease Translational Research Programme, Dy Director of the Cardiovascular Research Institute, Assistant Dean (Research), Head of the NUHS Clinician Scientist Academy, and Senior Consultant lead for the Cardiac Genetics Clinic, National University Heart Centre. He is a graduate of the Medical School at NUS, and spent 20 years abroad before returning to Singapore in 2013. His specialist training was undertaken at Kings College Hospital, London, and Addenbrooke’s Hospital, Cambridge. In 2003, he was awarded the Wellcome Trust Fellowship to pursue research at the Albert Einstein College of Medicine, New York, and returned to Cambridge in 2006 as a British Heart Foundation Fellow and Consultant Physician, before eventually returning to Singapore. His lab was the first to publish an epigenomic map of the failing human heart in 2012. More recently, his lab has published an in-depth analysis of the cardiac chromatin 3D organisation, and also reported the discovery of a long noncoding RNA, called Singheart, which regulates key cardiac gene expression. The approach of the lab is to deep dive into the epigenome of the heart, using advanced technology including single cell transcriptomics and Crispr-genome editing to explore frontiers, in continuing aspirations to discover novel avenues for therapies or biomarkers. Roger is also a keen advocate for the application of Next Generation sequencing based genomics to the clinic.